StockSelector.com
  Research, Select, & Monitor Sunday, September 23, 2018 5:31:50 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Concert Pharmaceuticals Inc.$13.52($.23)(1.67%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Concert Pharmaceuticals Inc. has an overall rank of 3983 out of 7243 stocks based on 9 positive rankings and 7 negative rankings.

Positive Rankings
Highest ROA
Concert Pharmaceuticals Inc. rank is 36
Debt-to-Equity
Concert Pharmaceuticals Inc. rank is 127
Historic Revenue Growth
Concert Pharmaceuticals Inc. rank is 153
Highest ROE
Concert Pharmaceuticals Inc. rank is 157
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Concert Pharmaceuticals Inc. is ranked 239.
Highest Cash Growth
Concert Pharmaceuticals Inc. rank is 989
Up EPS Surprise
Concert Pharmaceuticals Inc. beat the consensus earnings estimate when it last reported quarterly earnings.
Price-to-Book
Concert Pharmaceuticals Inc. rank is 1797
Price-to-Sales
Concert Pharmaceuticals Inc. rank is 2456
Negative Rankings
Negative Revenue Estimate
Concert Pharmaceuticals Inc. rank is 5
Negative EPS Growth
Concert Pharmaceuticals Inc. rank is 14
High vPut/Call
Concert Pharmaceuticals Inc. has a high Put/Call ratio of 2.54 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Concert Pharmaceuticals Inc. is ranked 309.
90 Day Loss
Concert Pharmaceuticals Inc. rank is 458
High Put/Call
Concert Pharmaceuticals Inc. has a high Put/Call ratio of 1.01 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Concert Pharmaceuticals Inc. is ranked 593.
10 Day Loss
Concert Pharmaceuticals Inc. rank is 725
Negative Net Margin
Concert Pharmaceuticals Inc. rank is 766







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.